Fishman Jay A Ltd. MI lifted its position in shares of Danaher Co. (NYSE:DHR) by 6.2% during the 4th quarter, HoldingsChannel reports. The fund owned 23,842 shares of the conglomerate’s stock after buying an additional 1,400 shares during the period. Fishman Jay A Ltd. MI’s holdings in Danaher were worth $2,213,000 at the end of the most recent reporting period.

Several other large investors have also recently made changes to their positions in DHR. Beach Investment Management LLC. lifted its stake in Danaher by 1,013.8% in the 2nd quarter. Beach Investment Management LLC. now owns 53,460 shares of the conglomerate’s stock valued at $4,511,000 after buying an additional 48,660 shares in the last quarter. Los Angeles Capital Management & Equity Research Inc. lifted its stake in Danaher by 511.9% in the 2nd quarter. Los Angeles Capital Management & Equity Research Inc. now owns 381,390 shares of the conglomerate’s stock valued at $32,186,000 after buying an additional 319,058 shares in the last quarter. AGF Investments America Inc. lifted its stake in Danaher by 29.6% in the 2nd quarter. AGF Investments America Inc. now owns 116,216 shares of the conglomerate’s stock valued at $9,807,000 after buying an additional 26,535 shares in the last quarter. Fiduciary Trust Co. lifted its stake in Danaher by 16.8% in the 2nd quarter. Fiduciary Trust Co. now owns 13,727 shares of the conglomerate’s stock valued at $1,158,000 after buying an additional 1,971 shares in the last quarter. Finally, Polaris Greystone Financial Group LLC lifted its stake in Danaher by 1.2% in the 2nd quarter. Polaris Greystone Financial Group LLC now owns 235,824 shares of the conglomerate’s stock valued at $19,901,000 after buying an additional 2,835 shares in the last quarter. 76.19% of the stock is currently owned by institutional investors and hedge funds.

Shares of Danaher Co. (DHR) opened at $95.25 on Thursday. The company has a market capitalization of $67,605.03, a price-to-earnings ratio of 24.08, a PEG ratio of 2.04 and a beta of 1.04. The company has a current ratio of 1.43, a quick ratio of 1.05 and a debt-to-equity ratio of 0.39. Danaher Co. has a twelve month low of $78.97 and a twelve month high of $104.82.

Danaher (NYSE:DHR) last released its quarterly earnings data on Tuesday, January 30th. The conglomerate reported $1.19 EPS for the quarter, topping analysts’ consensus estimates of $1.16 by $0.03. The business had revenue of $5.09 billion during the quarter, compared to the consensus estimate of $4.97 billion. Danaher had a return on equity of 11.36% and a net margin of 13.60%. The business’s revenue for the quarter was up 10.9% on a year-over-year basis. During the same period in the prior year, the firm posted $1.05 EPS. research analysts predict that Danaher Co. will post 4.37 earnings per share for the current year.

The firm also recently declared a quarterly dividend, which was paid on Friday, January 26th. Investors of record on Friday, December 29th were given a dividend of $0.14 per share. The ex-dividend date of this dividend was Thursday, December 28th. This represents a $0.56 dividend on an annualized basis and a yield of 0.59%. Danaher’s dividend payout ratio (DPR) is 15.86%.

In related news, SVP Daniel Raskas sold 37,870 shares of the company’s stock in a transaction on Thursday, November 16th. The shares were sold at an average price of $93.33, for a total transaction of $3,534,407.10. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP Angela S. Lalor sold 42,988 shares of the company’s stock in a transaction on Friday, February 2nd. The stock was sold at an average price of $102.29, for a total transaction of $4,397,242.52. Following the sale, the senior vice president now directly owns 82,008 shares of the company’s stock, valued at $8,388,598.32. The disclosure for this sale can be found here. Over the last ninety days, insiders have sold 274,913 shares of company stock valued at $27,729,293. 12.20% of the stock is owned by corporate insiders.

A number of research firms recently issued reports on DHR. Robert W. Baird reaffirmed a “buy” rating on shares of Danaher in a research note on Friday, January 12th. Credit Suisse Group boosted their price target on Danaher from $99.00 to $105.00 and gave the company an “outperform” rating in a report on Wednesday, January 31st. Zacks Investment Research downgraded Danaher from a “buy” rating to a “hold” rating in a report on Tuesday, December 19th. Stifel Nicolaus reiterated a “buy” rating and issued a $110.00 price target on shares of Danaher in a report on Friday, January 19th. Finally, Evercore ISI started coverage on Danaher in a report on Wednesday, January 3rd. They issued an “outperform” rating for the company. One research analyst has rated the stock with a sell rating, five have issued a hold rating, fourteen have given a buy rating and one has assigned a strong buy rating to the company’s stock. The stock currently has an average rating of “Buy” and a consensus price target of $100.13.

TRADEMARK VIOLATION NOTICE: This piece was first reported by Daily Political and is the property of of Daily Political. If you are viewing this piece on another site, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The legal version of this piece can be read at https://www.dailypolitical.com/2018/02/08/danaher-co-dhr-shares-bought-by-fishman-jay-a-ltd-mi.html.

About Danaher

Danaher Corporation (Danaher) designs, manufactures and markets professional, medical, industrial and commercial products and services. The Company operates through four segments: Life Sciences, which offers a range of research tools that scientists use to study the basic building blocks of life, including genes, proteins, metabolites and cells, in order to understand the causes of disease, identify new therapies and test new drugs and vaccines; Diagnostics; which offers analytical instruments, reagents, consumables, software and services; Dental, which provides products that are used to diagnose, treat and prevent disease and ailments of the teeth, gums and supporting bone, and Environmental & Applied Solutions, which consists of various lines of business, including water quality and product identification.

Want to see what other hedge funds are holding DHR? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Danaher Co. (NYSE:DHR).

Institutional Ownership by Quarter for Danaher (NYSE:DHR)

Receive News & Ratings for Danaher Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Danaher and related companies with MarketBeat.com's FREE daily email newsletter.